Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Current Opinion in Lipidology|November 22, 2011
Intestinal sterol transporters and cholesterol absorption inhibitionHarry R Davis, Andrew M Tershakovec, Joanne E Tomassini, et al.The American Journal of Cardiology|January 31, 2006
Striated muscle safety of ezetimibe/simvastatin (Vytorin)Michael H Davidson, Darbie Maccubbin, Michael Stepanavage, et al.Vascular Health and Risk Management|June 14, 2013
Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatinHelmut Steinberg, Matt S Anderson, Thomas Musliner, et al.Clinical Therapeutics|December 26, 2007
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniquesLeiv Ose, Robert Reyes, Amy O Johnson-Levonas, et al.Journal of Lipid Research|April 22, 2009
Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in menThomas Sudhop, Michael Reber, Diane Tribble, et al.The American Journal of Gastroenterology|January 26, 2002
The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy studyFrank Lanza, Bruce Sahba, Howard Schwartz, et al.Atherosclerosis|October 1, 2013
Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humansMichael H Davidson, Jason Voogt, Jayraz Luchoomun, et al.Pageof 1